Two analysts polled by Capital IQ called for a GAAP loss of $0.43 per share.
Revenue for the quarter was $643.9 million, down from $852.2 million reported a year earlier by the operator of senior living communities. Four analysts polled by Capital IQ expected $645.9 million.
For 2022, the company said it is expecting revenue per available unit growth of 10% to 12%.
Price: 5.38, Change: -0.01, Percent Change: -0.19
|-- Earnings Flash (AQS) AEQUUS PHARMACEUTICALS Repor...|
|Insider Buy: Bitnile Holdings|
|Insider Buy: Macerich|
|Insider Sell: Velodyne Lidar|
|Insider Sell: Xometry|